Allarity Therapeutics, Inc. (ALLR) investor relations documents from the company's IR site: 1 presentation, 1 press release; latest deck 2025-07-23. Read in-app with summaries. First-party data.
https://allarity.com/wp-content/uploads/2025/07/Allarity-Therapeutics-Corporate-Presentation-2025-Q2.pdf: Allarity Therapeutics (NASDAQ: ALLR) develops the DRP® companion diagnostic platform to predict patient-specific responses to cancer therapies.
| Published | Type | Document |
|---|---|---|
| 2026-03-31 | Press release | Link Complete Box |
| 2025-07-23 | Presentation | https://allarity.com/wp-content/uploads/2025/07/Allarity-Therapeutics-Corporate-Presentation-2025-Q2.pdf |
ALLR overview · ALLR earnings · ALLR financials · ALLR KPIs · ALLR ownership · ALLR peers · ALLR filings
Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.